Join Growin Stock Community!

友霖4166.TW Overview

TW StockBiotech. & Medical
(No presentation for 4166)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

友霖（4166）Overall Performance

友霖（4166）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

友霖（4166） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

友霖（4166）Key Information

友霖（4166）Profile

Orient Pharma Co., Ltd. engages in the research and development, manufacturing, and sales of drugs in Taiwan and internationally. The company develops anti-psychotics and psychostimulants, as well as drugs for treating Parkinson's and Alzheimer's diseases; and products for the treatment of sialorrhea, tuberculosis, and attention deficit hyperactivity disorder. It is also developing drug delivery technologies, such as multi-stages-controlled release technology, trans-dermal patches, oral disintegrating tablets, sustained release technology, and micro granules. The company was founded in 2008 and is based in Taipei, Taiwan.

友霖（4166）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
53.28%
Net Margin
8.04%
Revenue Growth (YoY)
7.63%
Profit Growth (YoY)
9.25%
3-Year Revenue Growth
35.02%
3-Year Profit Growth
78.84%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
Gross Margin
53.28%
Net Margin
8.04%
Revenue Growth (YoY)
7.63%
Profit Growth (YoY)
9.25%
3-Year Revenue Growth
35.02%
3-Year Profit Growth
78.84%
default symbol

4166

友霖

24.80D

-2.22%

(-0.02)

  • When is 4166's latest earnings report released?

    The most recent financial report for 友霖 (4166) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 4166's short-term business performance and financial health. For the latest updates on 4166's earnings releases, visit this page regularly.

  • Where does 4166 fall in the P/E River chart?

    According to historical valuation range analysis, 友霖 (4166)'s current price-to-earnings (P/E) ratio is 34.31, placing it in the Undervalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of 4166?

    According to the latest financial report, 友霖 (4166) reported an Operating Profit of 51.33M with an Operating Margin of 16.24% this period, representing a growth of 767.66% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is 4166's revenue growth?

    In the latest financial report, 友霖 (4166) announced revenue of 316.12M, with a Year-Over-Year growth rate of 5.16%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does 4166 have?

    At the end of the period, 友霖 (4166) held Total Cash and Cash Equivalents of 535.33M, accounting for 0.19 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 4166 go with three margins increasing?

    In the latest report, 友霖 (4166) achieved the “three margins increasing” benchmark, with a gross margin of 55.81%%, operating margin of 16.24%%, and net margin of 14.95%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 4166's profit trajectory and future growth potential.

  • What is the FCF of 4166?

    友霖 (4166)'s Free Cash Flow (FCF) for the period is -544.82M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 3,896.9% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.